GSK Paxil Hemihydrate Patent Claim Invalid, Court Says In Ruling For Apotex
This article was originally published in The Pink Sheet Daily
Executive Summary
SmithKline’s early clinical trials on the safety and efficacy of paroxetine hemihydrate as an antidepressant did not constitute an “experimental use” of the claimed invention, the court says.